Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
doi:10.1038/onc.2008.21
Enhances mental focus and cognitive performance
Many patients notice improved mobility and less morning stiffness
2035 Mapping Treatment-Induced Adverse Events against HRQoL Questionnaires in Non-Small Cell Lung Cancer: Evaluation of the EORTC QLQ-C30 and QLQ-LC29 Lotte Van der Weijst 1 , Cecilia Pompili 2,3 , Maria Teixeira 4 , Hayat Hamzeh 5 , Claire Piccinin 4 , Madeline Pe 4 1 EORTC, Brussels, Belgium, 2 Institute for Clinical & Applied Health Research, University of Hull, UK, 3 Section of Patient Centred Outcomes Research, University of Leeds, UK, 4 Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium, 5 Leeds Institute of Medical Research, University of Leeds, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2035 Aims This study aims to evaluate the relevance of health-related quality of life (HRQoL) questionnaires in capturing treatment-induced adverse events
US$ 20.21
US$ 23.03
US$ 28.27
US$ 26.06
